Page 2283 - Williams Hematology ( PDFDrive )
P. 2283

2258           Part XII:  Hemostasis and Thrombosis                                                                                                                        Chapter 132:  Thrombotic Microangiopathies            2259




               TTP usually occurs in the third trimester or postpartum, whereas fetal   STEC causes HUS (STEC-HUS) that is usually is associated with a pro-
               loss is most common in the second trimester. 109       drome of diarrhea. Other names in the literature for STEC-HUS include
                                                                      diarrhea-associated HUS (D+HUS) and “typical” HUS.
               LABORATORY FEATURES                                        In 1955, the term  HUS was proposed for thrombotic microan-
               Severe congenital ADAMTS13 deficiency (<5 percent) is characteristic   giopathy occurring in children and associated with acute anuric renal
                                                                                                 115
               of congenital TTP. Alloantibodies to ADAMTS13 as a consequence of   failure, which is uncommon in TTP.  HUS was often preceded by a
               treatment with plasma are extremely rare in congenital TTP; only one   diarrheal illness and, unlike TTP in adults, the prognosis was relatively
               such patient has been reported.  Other laboratory findings in congen-  favorable. Most patients survived and recovered normal renal function
                                      110
                                                                                         116
               ital TTP are similar to those in acquired TTP. The histologic features of   with only supportive care.  Although cases were known to cluster in
               congenital TTP are similar to those of acquired TTP. 111  endemic areas, the cause of HUS was unknown until 1983, when E. coli
                                                                      O157:H7 was shown to express a Shiga-like toxin and cause epidemic
                                                                      hemorrhagic colitis that could evolve into HUS. 117–119
               DIFFERENTIAL DIAGNOSIS
               For patients presenting during early childhood, other causes of throm-  ETIOLOGY AND PATHOGENESIS
               botic microangiopathy to consider include STEC-HUS, atypical HUS
               and secondary thrombotic microangiopathy associated with disorders   STEC may make two types of Shiga toxin (Stx) that are similar in struc-
               that are characteristic of childhood. For adolescents and adults, the dif-  ture and function to ricin. Stx1 is identical to Shigella dysenteriae sero-
               ferential diagnosis is the same as for acquired TTP (see Table  132–1).  type 1 toxin. Stx2 is approximately 50 percent identical in sequence to
                   Testing of stool and urine for STEC should be considered for all   Stx1 and occurs in several closely related forms. Both toxins consist
               patients with thrombotic microangiopathy because a significant frac-  of  pentameric  B  subunits  that  bind  globotriaosylceramide  (Gb3)  on
               tion of patients with STEC infection never have bloody diarrhea.  cell surfaces and a single A subunit that is responsible for cytotoxicity.
                                                                      Pathogenic E. coli almost always express a variant of Stx2 and approxi-
               THERAPY                                                mately two-thirds express Stx1. 120
                                                                          When STEC colonize the gut they damage the epithelium and
               Congenital TTP can be treated with periodic infusions of fresh-frozen   secrete Stx that is delivered to target organs through the blood, probably
               plasma or an equivalent virucidally treated product, if available. The   by neutrophils. Stx bound to Gb3 on cell surfaces is endocytosed and
               half-life of ADAMTS13 is 2 to 3 days  and the level of ADAMTS13   transported in a retrograde fashion through the secretory pathway to
                                           112
               required to avoid symptoms is approximately 5 percent of normal;     the endoplasmic reticulum, where the A subunit is translocated into the
               5 to 20 mL/kg of plasma every 2 to 3 weeks usually is sufficient to main-  cytoplasm. The A subunit is an N-glycosidase that removes a specific
               tain ADAMTS13 at a greater than 5 percent level and prevent symp-  base from the large ribosomal subunit, which inhibits protein synthesis
               toms. 105,107  Patients with severe allergic reactions to plasma have been   and activates a response pathway that leads to apoptosis. The observed
               treated successfully with plasma-derived factor VIII/VWF concentrates   predilection for renal injury is a result of the relatively high expression
               that contain significant amounts of ADAMTS13. 55       of Gb3 on renal tubular epithelial, mesangial, and glomerular endothe-
                                                                      lial cells.
               Pregnancy Management
               Fetal loss and premature birth can be prevented by plasma infusions
               10 mL/kg every 2 weeks beginning at 8 weeks of gestation, increasing   EPIDEMIOLOGY
               to weekly in the second trimester. Any sign of thrombotic microangio-  STEC-HUS can occur at any age but affects mainly children younger
               pathy is an indication to increase the volume or frequency of plasma   than age 5 years and is rare before age 6 months. The disease occurs spo-
               infusion. Plasma exchange may be necessary to avoid fluid overload. 55,109  radically and in epidemics, associated with ingestion of foods or other
                                                                      materials contaminated with Stx-producing bacteria. E. coli O157:H7
               COURSE AND PROGNOSIS                                   accounts for at least 80 percent of cases in many series, but STEC-HUS
                                                                      can be caused by other toxin-bearing E. coli serotypes
                                                                                                                 or by S. dys-
                                                                                                             121,122
               The severity of congenital TTP varies considerably and correlates   enteriae type 1. Most cases occur in summer and autumn in rural envi-
               to some extent with the underlying genotype and residual plasma   ronments. The incidence is approximately 10 to 30 per million children
               ADAMTS13 activity. Patients with ADAMTS13 activity of less than 2.5   per year, but depends on the risk of exposure, which varies considerably
               percent of normal tend to have their first TTP episode in childhood,   with the time of year, location, and other factors. STEC-HUS is a com-
               have more than one episode of TTP per year, and require regular plasma   mon cause of chronic renal failure in children. 120
               prophylaxis.  Conversely,  patients  with  ADAMTS13  activity  of  2.5  to
               6.0 percent tend to present in adulthood and have infrequent episodes   CLINICAL FEATURES
               of disease. 113,114  Some of these patients have prolonged symptom-free
               intervals and can be treated on demand. However, inadequately treated   Patients develop abdominal pain, tenderness and diarrhea between 2
               patients are at risk for developing chronic renal failure and stroke. 55  and 12 days after ingesting STEC, with a mean incubation period of 3
                                                                      to 7 days and a median of 3 days. The diarrhea usually becomes bloody
                                                                      within 1 to 3 days, at which time patients are typically afebrile. Nausea
                    SHIGA TOXIN ESCHERICHIA                           and vomiting are common. The abdominal pain is greater than is typical
                  COLI–ASSOCIATED HEMOLYTIC                           for other causes of gastroenteritis, and defecation is often painful. Most
                  UREMIC SYNDROME                                     patients recover spontaneously within a few days. Of children younger
                                                                      than 10 years of age with bloody diarrhea and E. coli O157:H7 infec-
                                                                      tion, approximately 15 percent will develop STEC-HUS with the acute
               DEFINITION AND HISTORY                                 onset of microangiopathic hemolytic anemia, thrombocytopenia, and
               HUS refers to thrombotic microangiopathy that mainly affects the   renal injury an average of 7 days (range: 5 to 13 days) after the start of
               kidney and usually causes oliguric or anuric renal failure. Ingestion of   diarrhea. 120






          Kaushansky_chapter 132_p2253-2266.indd   2258                                                                 17/09/15   3:47 pm
   2278   2279   2280   2281   2282   2283   2284   2285   2286   2287   2288